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ABSTRACT
Background:We report a neonatal case of cystic periventricular leukomalacia (PVL) in which the hypoxia
was considered to have been caused by severe asthma in the mother, who had not taken any medication dur-
ing pregnancy because she was anxious about its possible effects on her unborn child.
Methods: After the mother had severe exacerbation of asthma for five days, the baby was born at 36 weeks in
gestation, weighing 2100 g, and with moderate asphyxia. Although the baby had been aggressively treated in a
neonatal intensive care unit, at birth, an ischemic area had been formed in the periventricular areas in the brain
echogram. We suspected that she had severe brain damage due to prenatal hypoxia.
Results: The baby was found to have cystic PVL by ultrasonography at age 15 days, and diplegia at age 4
months.
Conclusions: The poorly controlled, persistent and severe asthma of the mother may have caused prenatal
hypoxia, resulting in the cystic PVL and lower limb palsy. Pregnant patients with poorly controlled asthma
should be advised of the great risk of this condition to the fetus. Also, patients should be assured of the safety
of modern asthma treatments.
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INTRODUCTION
Poorly controlled asthma during pregnancy might
lead have an adverse effect on the fetus, resulting in
increased perinatal mortality, increased risk of pre-
maturity, and low birth weight.1 Acute exacerbation
should be treated aggressively in order to avoid fetal
hypoxia. It is more important to maintain good man-
agement in order to avoid exacerbation of asthma.
These are spelled out in the Global Initiative for
Asthma (GINA).2
In our Neonatal Intensive Care Unit (NICU), we
treated a baby whose mother had a severe attack of
bronchial asthma. Unfortunately, PVL was diagnosed
in the baby: hypoxic necrosis had occurred in the
periventricular area, and caused cerebral palsy.
CLINICAL SUMMARY
A pregnant 29-year-old Japanese woman with a gesta-
tional age of 35 weeks and 3 days was transferred to
our emergency room in November 2004 because of
status asthmaticus.
She had been treated for bronchial asthma from 4
years of age, and had been hospitalized several times
for severe bronchial asthma attacks. After she was de-
livered of a baby for the first time, she was admitted
to the hospital for asthma deterioration in 2003.
Thereafter she had been treated for asthma with in-
haled corticosteroid (fluticasone dipropionate) , and
oral theophylline . When she became aware of her
second pregnancy, she unilaterally tried to discon-
tinue all medications. However, she needed to use
metered-dose inhalation of β2-stimulant frequently.
During the night, she suffered from asthma attacks
leading to dyspnea and her symptoms gradually be-
came worse. Thereafter she consulted a doctor in a
local hospital. Although she was treated by inhalation
therapy with oxygen and β2-stimulant again, she de-
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Fig. 1 Brain echogram at birth showing bilateral periventricular high-echoic lesions.
Fig. 2 Brain echogram on day 15: cystic lesions are seen bilateraly in the periventricular areas.
veloped respiratory failure. She was then intubated
and transferred to our hospital for the care of her
baby in the NICU.
PATHOLOGICAL FINDINGS
On admission, the mother’s arterial blood gas analy-
sis showed pH 7.033, PCO2 104.9 mmHg, PO2 144.6
mmHg, while FiO2 was 0.6. After admission, she was
transferred to our ICU, and was treated with intrave-
nous methylprednisolone, an intravenous drip infu-
sion of aminophylline, and salbutamol sulfate MDI for
the asthma. She was also given mechanical ventila-
tion, and sedated with midazolam, buprenorphine ,
and pentazocine. She improved gradually , and was
extubated 2 days after admission. At this time, her fe-
tal non-stress-test (NST) showed no acceleration, but
the fetal heart rate was over 120 per minute. On the
5th day of hospitalization, she still needed supple-
mental oxygen, and her labor pains began. At that
time, the fetal NST was partially reactive. Soon after
the labor pains started, the baby was delivered.
The child was a girl, breech-delivered at 36 weeks
of gestation, with a birth weight of 2100 g. During la-
bor, the amniotic fluid was opaque, so the neonatolo-
gist immediately suctioned fluid from the baby’s tra-
chea. The Apgar score was 57 points . Meconium
was suctioned from the trachea , which was then
washed with diluted surfactant . Artificial ventilation
was initiated to control the infant’s respiration, and
monitored her PCO2 and PO2 by transcutaneously. At
the time of admission to NICU, her venous blood
gases showed no sign of acidosis (pH 7.368, PCO2
43.3 mmHg, PO2 44 mmHg, HCO3− 24.9, and BE 0),
and her chest X-ray findings showed very mild infil-
tration as mild meconium aspiration syndrome. Dur-
ing artificial ventilation , we maintained her PCO2
around 40 mmHg. Consequently, it was possible to
wean the baby from artificial ventilation on the day af-
ter admission. After weaning, her clinical course was
very satisfactory , and from 3 days after birth , she
could suckle milk, though her sucking was sluggish.
Soon after birth , her brain echogram revealed
periventricular high-echoic lesions bilaterally (Fig. 1),
and so we followed these changes. On day 15, we
found periventricular cystic lesions in the brain
echogram appearing as cystic PVL (Fig. 2), and on
day 16, brain magnetic resonance (MR) imaging re-
vealed PVL. T1-weighted MR imaging showed high-
signal lesions in both periventricular areas, and these
findings extended into the parietal area (Fig. 3). T2-
weighted MR imaging showed low-signal lesions on
T1-weighted MR imaging (Fig. 4).
The auditory brainstem response was normal, and
the clinical course was uneventful , so she was dis-
charged from our hospital on day 22. After discharge,
the baby was followed up in our outpatient division.
At 2 months of age, we performed MR imaging again.
T1-weighted MR imaging demonstrated high-signal
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Fig. 3　T1-weighted brain MR imaging shows high-signal regions in the periventricular areas at 
day 16.
Fig. 4 T2-weighted brain MR imaging shows low-signal regions and cystic regions in the 
periventricular areas, which extended to the parietal area at day 16.
lesions in both periventricular area. The ventricular
wall was serrated and the white matter of the brain
was atrophic (Fig. 5). In the periventricular area, T2-
weighted MR imaging showed low-signal lesions
(Fig. 6).
A diagnosis of cerebral palsy with diplegia was
made at 4 months and she was treated with neuro-
developmental therapy.
DISCUSSION
We report a neonatal case of cystic PVL, due to fetal
hypoxia. The hypoxia was caused by the mother’s se-
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Fig. 5 At 2 months of age, T1-weighted brain MR imaging shows high-signal regions in the 
periventricular area, atrophy of the white mater and serated ventricular wals.
Fig. 6 At 2 months of age, T2-weighted brain MR imaging shows low-signal regions in the 
periventricular area, atrophy of the white mater and serated ventricular wals.
vere asthma attacks . Although the mother needed
controller medication and anti-inflammatory agents
such as inhaled corticosteroids, she had stopped tak-
ing her controller medication, and status asthmaticus
ensued. To the best of our knowledge, there are no
previous report demonstrating a neonatal case of cys-
tic PVL in which the hypoxia was caused by severe
asthma in the mother.
Bronchial asthma is a common complication of
pregnancy, occurring in between 3.7 and 8.4 percent
of pregnant women, according to United States na-
tional health surveys spanning 1997 to 2001. 3 Asth-
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matic women have a greater risk of complications
during pregnancy, for example, perinatal mortality ,
pre-eclampsia , low-birth-weight infants , transient
tachypnea of the newborn, 4,5 meconium stain 6 and
preterm births, than non-asthmatic women. This is
especially true in severely asthmatic women.1,7,8 How-
ever, when the asthma is well-controlled, the perina-
tal risk can be decreased.1,9,10
Severe, life-threatening asthma or status asthmati-
cus occurs in 0.05 to 0.2%11,12 of all pregnancies. Gor-
don et al.11 reported that some patients with severe
asthma had neurologically abnormal infants, as in the
present case. Another study reported that the inci-
dence of newborn hypoxia was significantly higher in
asthmatic mothers.13 Not only hypoxia but also hy-
percapnia in an asthmatic mother can result in fetal
respiratory acidosis and in a shift of the fetal hemo-
globin dissociation curve to the right , limiting the
ability of fetal hemoglobin to bind to oxygen.14
PVL is a problem that causes neurological disabili-
ties, for example, learning disabilities, cerebral palsy
and mental retardation, and occurs most frequently in
premature infants. The white matter of these fetuses
is poorly vascularized and contains oligodendrocyte
progenitors , which are sensitive to the effects of
ischemia and infarction, and since PVL is an ischemic
reperfusion injury of the white matter, it causes focal
necrotic cystic lesions.15-17 Moreover, these cystic le-
sions formed about 14 days after ischemic injury .
Once PVL has occurred, there is no effective treat-
ment, thus prevention is important . In the present
case, we found completely cystic areas on echogra-
phy at 15 days after birth. Although muddy amniotic
fluid was present, a skillful neonatologist was fortu-
nately available to treat the infant, and the infant’s tra-
chea was quickly cleared and cleaned, so her respira-
tion was soon well under control; but unfortunately,
this was not soon enough to prevent the PVL that re-
sulted from hypoxia during the mother’s status asth-
maticus.
In a population-based Norwegian study in low-
birth-weight infants , with registration of cerebral
palsy, 44% of the subjects had a perinatal etiology,
most frequently intra- or periventricular hemorrhage,
or PVL, or cerebral infarction.18 In Japan, Fujimoto et
al. reported the incidence of PVL at one-third of cere-
bral palsy cases.19 In such cases, it is important for
the medical staff to provide parents with adequate
preparation and explanation, to offer to carry out re-
habilitation on the baby, and to follow the case peri-
odically . After the baby with cystic PVL was dis-
charged, a neonatologist has been closely involved.
She started early rehabilitation because she showed
spastic palsy in the lower limbs.
In 2004, a NAEPP (National Asthma Education and
Prevention Program) Expert Panel Report offered
recommendations for pharmacologic asthma manage-
ment during pregnancy . Fundamentally , asthma
treatment based on corticosteroid inhalation does not
require modification even during pregnancy.20 In the
present case, PVL could probably have been avoided
if the mother’s asthma had been well controlled, but
the mother was apprehensive about taking medica-
tions during pregnancy. Physicians and other medi-
cal staff should explain the necessity of well control in
pregnancy to asthmatic women . If patients with
asthma become pregnant, medical providers should
explain the safety of inhalation corticosteroid therapy
for both the pregnant woman and the fetus. These
treatments and procedures are for the sake of the
well-being of both mother and fetus . Pediatricians
must also educate asthmatic children to maintain
strict adherence to their asthma medication regi-
mens.
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